MS
TPST icon

Maven Securities’s Tempest Therapeutics TPST Stock Holding History

Maven Securities’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,952
Closed -$409K – 1107
2021
Q4 		$409K Sell
5,952
-3,808
-39% -$525K 0.01% 606
2021
Q3 		$1.84M Buy
9,760
+1,558
+19% +$303K 0.06% 266
2021
Q2 		$1.2M Buy
+8,202
New +$1.84M 0.05% 373

Other funds holding TPST

RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Maven Securities's TPST Position: Q1 2022 in Review

Maven Securities sold out of Tempest Therapeutics (TPST) in Q1 2022, closing a stake of 5,952 shares — an estimated $409K sold.

Maven Securities first reported a position in TPST in Q2 2021 and held it in 3 quarters. The position peaked at $1.84M in Q3 2021. 15 funds tracked by Wall St. Rank hold TPST as of Q1 2022.

  • Maven Securities reported no remaining Tempest Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Maven Securities sold 5,952 Tempest Therapeutics shares in Q1 2022, an estimated $409K.
  • Maven Securities first reported a position in Tempest Therapeutics in Q2 2021 and held it in 3 quarters.
  • Maven Securities's Tempest Therapeutics position peaked at $1.84M in Q3 2021.
  • 15 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2022.

Based on Maven Securities's 13F filing for Q1 2022, filed 16 May 2022.